Advertisement
Home2024-01-11T09:26:42-05:00

Top Story

  • Health Policy
    February 21st, 2024

    Three pharmaceutical companies—GSK, Kaléo, and Amneal—have agreed to delist several patents in response to the Federal Trade Commission's (FTC) November challenge, aiming to increase competition by addressing alleged misuse of the patent system. GSK will remove 17 patents related to its inhalers, while Kaléo and Amneal [...]

HEOR

RWE

Advertisement

Featured Webinars

Handpicked Promotions & Highlights

Latest in Catalyst News powered by BioPharmCatalyst

02/21/2024 04:46 PM ET

Regeneron Pharmaceuticals REGN date announcement

Regeneron Pharmaceuticals now has 20 catalyst announcements on the calendar after revealing the date on which they will release trial results for Linvoseltamab (REGN5458) - (LINKER-MM1). On March 31, 2024, Regeneron Pharmaceuticals will announce top-line [...]

Read More
02/21/2024 04:46 PM ET

Ionis Pharmaceuticals IONS earnings announcement

Ionis Pharmaceuticals revealed their most recent quarterly earnings data, in which both revenue and EPS ended up higher than estimates. Revenue was reported to be $325M and EPS was -$0.06. Ionis Pharmaceuticals' EPS is [...]

Read More
02/21/2024 04:46 PM ET

PHAXIAM Therapeutics S.A. THTX earnings announcement

Theratechnologies beat their EPS estimate and fell in line with their revenue estimate, according to their recent quarterly earnings data. Revenue was $23.45M, exceeding estimates by 0.39%. For revenue, that is [...]

Read More
02/21/2024 04:46 PM ET

Ventyx Biosciences UTHR earnings announcement

United Therapeutics Corporation exceeded their revenue estimate and fell in line with their EPS estimate, according to their recent quarterly earnings data. The revenue estimate was $575.87M, but the actual figure was [...]

Read More

Latest From Our Blog

Receive essential insights, resources and content direct to your inbox

Hit subscribe to stay informed!

Go to Top